Comparative Analysis of Species-Specific Ligand Recognition in Toll-Like Receptor 8 Signaling: A Hypothesis

Toll-like receptors (TLRs) play a central role in the innate immune response by recognizing conserved structural patterns in a variety of microbes. TLRs are classified into six families, of which TLR7 family members include TLR7, 8, and 9, which are localized to endolysosomal compartments recognizing viral infection in the form of foreign nucleic acids. In our current study, we focused on TLR8, which has been shown to recognize different types of ligands such as viral or bacterial ssRNA as well as small synthetic molecules. The primary sequences of rodent and non-rodent TLR8s are similar, but the antiviral compound (R848) that activates the TLR8 pathway is species-specific. Moreover, the factors underlying the receptor's species-specificity remain unknown. To this end, comparative homology modeling, molecular dynamics simulations refinement, automated docking and computational mutagenesis studies were employed to probe the intermolecular interactions between this anti-viral compound and TLR8. Furthermore, comparative analyses of modeled TLR8 (rodent and non-rodent) structures have shown that the variation mainly occurs at LRR14-15 (undefined region); hence, we hypothesized that this variation may be the primary reason for the exhibited species-specificity. Our hypothesis was further bolstered by our docking studies, which clearly showed that this undefined region was in close proximity to the ligand-binding site and thus may play a key role in ligand recognition. In addition, the interface between the ligand and TLR8s varied depending upon the amino acid charges, free energy of binding, and interaction surface. Therefore, our current work provides a hypothesis for previous in vivo studies in the context of TLR signaling.

[1]  S. Paik,et al.  Crystal Structure of the TLR1-TLR2 Heterodimer Induced by Binding of a Tri-Acylated Lipopeptide , 2007, Cell.

[2]  Sangdun Choi,et al.  Toll-like receptor modulators: a patent review (2006 – 2010) , 2011, Expert opinion on therapeutic patents.

[3]  A. Ishii,et al.  Combinational recognition of bacterial lipoproteins and peptidoglycan by chicken Toll-like receptor 2 subfamily. , 2008, Developmental and comparative immunology.

[4]  Shaila C. Rössle,et al.  Homology modeling of human Toll‐like receptors TLR7, 8, and 9 ligand‐binding domains , 2009, Protein science : a publication of the Protein Society.

[5]  Adriaan P IJzerman,et al.  Selective allosteric enhancement of agonist binding and function at human A3 adenosine receptors by a series of imidazoquinoline derivatives. , 2002, Molecular pharmacology.

[6]  Hayyoung Lee,et al.  Crystal Structure of the TLR4-MD-2 Complex with Bound Endotoxin Antagonist Eritoran , 2007, Cell.

[7]  L. Babiuk,et al.  Porcine TLR8 and TLR7 are both activated by a selective TLR7 ligand, imiquimod. , 2008, Molecular immunology.

[8]  Zsolt Bikádi,et al.  Application of the PM6 semi-empirical method to modeling proteins enhances docking accuracy of AutoDock , 2009, J. Cheminformatics.

[9]  D. Werling,et al.  Host species-specific usage of the TLR4-LPS receptor complex , 2008, Innate immunity.

[10]  B. Monks,et al.  Ligand-induced conformational changes allosterically activate Toll-like receptor 9 , 2007, Nature Immunology.

[11]  Gert Vriend,et al.  Making optimal use of empirical energy functions: Force‐field parameterization in crystal space , 2004, Proteins.

[12]  T. Giese,et al.  Quantitative Expression of Toll-Like Receptor 1–10 mRNA in Cellular Subsets of Human Peripheral Blood Mononuclear Cells and Sensitivity to CpG Oligodeoxynucleotides1 , 2002, The Journal of Immunology.

[13]  Y. Kuroki,et al.  Comparative sequence analysis of leucine-rich repeats (LRRs) within vertebrate toll-like receptors , 2007, BMC Genomics.

[14]  François Stricher,et al.  The FoldX web server: an online force field , 2005, Nucleic Acids Res..

[15]  Marion Jurk,et al.  Modulating responsiveness of human TLR7 and 8 to small molecule ligands with T‐rich phosphorothiate oligodeoxynucleotides , 2006, European journal of immunology.

[16]  Jongdae Lee,et al.  Molecular basis for the immunostimulatory activity of guanine nucleoside analogs: Activation of Toll-like receptor 7 , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[17]  Sangdun Choi,et al.  Molecular Modeling-Based Evaluation of hTLR10 and Identification of Potential Ligands in Toll-Like Receptor Signaling , 2010, PloS one.

[18]  Shaila C. Rössle,et al.  TollML: a database of toll-like receptor structural motifs , 2010, Journal of molecular modeling.

[19]  Sandor Vajda,et al.  ClusPro: a fully automated algorithm for protein-protein docking , 2004, Nucleic Acids Res..

[20]  P. Nordlund,et al.  The Crystal Structure of the Human Toll-like Receptor 10 Cytoplasmic Domain Reveals a Putative Signaling Dimer* , 2008, Journal of Biological Chemistry.

[21]  L. Babiuk,et al.  Characterization of bovine Toll-like receptor 8: ligand specificity, signaling essential sites and dimerization. , 2009, Molecular immunology.

[22]  O. Jann,et al.  Variation matters: TLR structure and species-specific pathogen recognition. , 2009, Trends in immunology.

[23]  D. Eisenberg,et al.  VERIFY3D: assessment of protein models with three-dimensional profiles. , 1997, Methods in enzymology.

[24]  H. Wagner,et al.  Human TLR7 or TLR8 independently confer responsiveness to the antiviral compound R-848 , 2002, Nature Immunology.

[25]  J. Metzger,et al.  Toll‐like receptor 9 binds single‐stranded CpG‐DNA in a sequence‐ and pH‐dependent manner , 2004, European journal of immunology.

[26]  M. Tomai,et al.  Induction of cytokines in cynomolgus monkeys by the immune response modifiers, imiquimod, S-27609 and S-28463. , 1997, Cytokine.

[27]  John P. Vasilakos,et al.  Cutting Edge: Activation of Murine TLR8 by a Combination of Imidazoquinoline Immune Response Modifiers and PolyT Oligodeoxynucleotides , 2006, The Journal of Immunology.

[28]  Junmei Wang,et al.  How well does a restrained electrostatic potential (RESP) model perform in calculating conformational energies of organic and biological molecules? , 2000, J. Comput. Chem..

[29]  S. Akira,et al.  Pathogen recognition by innate immunity and its signaling , 2009, Proceedings of the Japan Academy. Series B, Physical and biological sciences.

[30]  S. Akira,et al.  The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors , 2010, Nature Immunology.

[31]  S. Akira,et al.  The Toll‐like receptor 7 (TLR7)‐specific stimulus loxoribine uncovers a strong relationship within the TLR7, 8 and 9 subfamily , 2003, European journal of immunology.

[32]  David S. Goodsell,et al.  AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility , 2009, J. Comput. Chem..

[33]  Sankar Ghosh,et al.  Recognition and signaling by toll-like receptors. , 2006, Annual review of cell and developmental biology.

[34]  T. Yeates,et al.  Verification of protein structures: Patterns of nonbonded atomic interactions , 1993, Protein science : a publication of the Protein Society.

[35]  András Fiser,et al.  ModLoop: automated modeling of loops in protein structures , 2003, Bioinform..

[36]  R. Miller,et al.  The imidazoquinolines, imiquimod and R-848, induce functional, but not phenotypic, maturation of human epidermal Langerhans' cells. , 2000, Clinical immunology.

[37]  S. Akira,et al.  Small anti-viral compounds activate immune cells via the TLR7 MyD88–dependent signaling pathway , 2002, Nature Immunology.

[38]  L. Federici,et al.  The crystal structure of polygalacturonase-inhibiting protein (PGIP), a leucine-rich repeat protein involved in plant defense , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[39]  J. V. van Putten,et al.  The Central Leucine-Rich Repeat Region of Chicken TLR16 Dictates Unique Ligand Specificity and Species-Specific Interaction with TLR21 , 2007, The Journal of Immunology.

[40]  Andrey Tovchigrechko,et al.  GRAMM-X public web server for protein–protein docking , 2006, Nucleic Acids Res..

[41]  S. Akira,et al.  Pathogen Recognition and Innate Immunity , 2006, Cell.

[42]  S. Akira,et al.  Species-Specific Recognition of Single-Stranded RNA via Toll-like Receptor 7 and 8 , 2004, Science.

[43]  G. Barton Viral recognition by Toll-like receptors. , 2007, Seminars in immunology.

[44]  D. Davies,et al.  Leucine-rich repeats and pathogen recognition in Toll-like receptors. , 2003, Trends in immunology.

[45]  D. Davies,et al.  The molecular structure of the TLR3 extracellular domain , 2006, Journal of endotoxin research.

[46]  B. Monks,et al.  Toll-like receptor 4 imparts ligand-specific recognition of bacterial lipopolysaccharide. , 2000, The Journal of clinical investigation.

[47]  D. Bernstein,et al.  Daily or weekly therapy with resiquimod (R-848) reduces genital recurrences in herpes simplex virus-infected guinea pigs during and after treatment. , 2001, The Journal of infectious diseases.

[48]  S. Paik,et al.  Recognition of lipopeptide patterns by Toll-like receptor 2-Toll-like receptor 6 heterodimer. , 2009, Immunity.

[49]  T L Blundell,et al.  FUGUE: sequence-structure homology recognition using environment-specific substitution tables and structure-dependent gap penalties. , 2001, Journal of molecular biology.

[50]  A. Aderem,et al.  A conserved surface on Toll-like receptor 5 recognizes bacterial flagellin , 2007, The Journal of experimental medicine.

[51]  D. Davies,et al.  Structural Basis of Toll-Like Receptor 3 Signaling with Double-Stranded RNA , 2008, Science.

[52]  B. Kobe,et al.  The leucine-rich repeat as a protein recognition motif. , 2001, Current opinion in structural biology.

[53]  Shizuo Akira,et al.  Toll-like receptor signalling , 2004, Nature Reviews Immunology.

[54]  C. Bryant,et al.  The equine TLR4/MD-2 complex mediates recognition of lipopolysaccharide from Rhodobacter sphaeroides as an agonist , 2007, Journal of endotoxin research.

[55]  I. Wilson,et al.  Crystal Structure of Human Toll-Like Receptor 3 (TLR3) Ectodomain , 2005, Science.

[56]  R. Xiang,et al.  A five-amino-acid motif in the undefined region of the TLR8 ectodomain is required for species-specific ligand recognition. , 2010, Molecular immunology.

[57]  R. Miller,et al.  Cytokine induction in hairless mouse and rat skin after topical application of the immune response modifiers imiquimod and S-28463. , 1998, The Journal of investigative dermatology.

[58]  Hayyoung Lee,et al.  The structural basis of lipopolysaccharide recognition by the TLR4–MD-2 complex , 2009, Nature.

[59]  B. Beutler TLRs and innate immunity. , 2009, Blood.

[60]  Manfred J. Sippl,et al.  Thirty years of environmental health research--and growing. , 1996, Nucleic Acids Res..

[61]  Sandor Vajda,et al.  ClusPro: an automated docking and discrimination method for the prediction of protein complexes , 2004, Bioinform..

[62]  Sangdun Choi,et al.  In Silico Approach to Inhibition of Signaling Pathways of Toll-Like Receptors 2 and 4 by ST2L , 2011, PloS one.

[63]  N. Gay,et al.  Conserved Features in the Extracellular Domain of Human Toll-like Receptor 8 Are Essential for pH-dependent Signaling* , 2006, Journal of Biological Chemistry.

[64]  J. Thornton,et al.  AQUA and PROCHECK-NMR: Programs for checking the quality of protein structures solved by NMR , 1996, Journal of biomolecular NMR.

[65]  A. Kaur,et al.  The evolution of vertebrate Toll-like receptors. , 2005, Proceedings of the National Academy of Sciences of the United States of America.